Politics By Lev Facher FDA blasts Alkermes for underselling the risks of opioid addiction drug Vivitrol
First Opinion By Patrick J. Kennedy Mental health and addiction care are poorly covered by insurance networks
Health By Andrew Joseph Tufts will scour Sackler name from its medical campus, in rebuff of family that controls Purdue Pharma
Exclusive By Casey Ross Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show
First Opinion By Judith Feinberg The view from West Virginia: the end of HIV transmission is a distant dream
First Opinion By Alister Martin and Ted Robertson Changing emergency doctors’ behaviors to promote wider use of medication for opioid use disorder
Pharma By David Armstrong — ProPublica How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic
Politics By Lev Facher A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission
Off the Charts By Jennifer Adaeze Okwerekwu When it comes to health care, nothing is nonpartisan. Melania Trump’s visit to a Boston hospital harms patients and providers
Health By Andrew Joseph With a new guide to tapering opioids, federal health officials seek a balanced approach to prescribing
Health By Shraddha Chakradhar ‘Sesame Street’ launches new initiative to help explain parental addiction to kids
First Opinion By Adam Dean and Simeon Kimmel Beyond the Sacklers: Free-trade policies contributed to the opioid epidemic
Business By Andrew Joseph Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer?
Pharma By Andrew Joseph Historians push to create public archive of documents from massive opioid litigation
First Opinion By Kathleen T. Brady Don’t let the opioid settlement fritter away funds like the tobacco settlement did
Pharma By Associated Press OxyContin maker Purdue Pharma agrees to tentative settlement in opioid lawsuits
Health By David Armstrong and Jeff Ernsthausen — ProPublica Purdue Pharma touts data that downplay its role in the opioid epidemic, new analysis shows
First Opinion By James Baird Every hospital needs ‘recovery coaches’ for patients with substance use problems
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Purdue, J&J, and a week of big opioid crisis news
Pharma By David Armstrong — ProPublica Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing
Pharma By Andrew Joseph and Casey Ross STAT wins long legal fight as Kentucky Supreme Court clears way for release of Purdue OxyContin files
Politics By Lev Facher In bid to improve care, Trump administration to relax privacy rules for patients with history of addiction
Health By Brittany Flaherty For the first time, U.S. panel recommends screening adults for illicit drug use
